Walleye Trading
FATE icon

Walleye Trading’s Fate Therapeutics FATE Stock Holding History

Walleye Trading’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-30,400
Closed -$307K – 4989
2022
Q4 		$307K Buy
30,400
+16,800
+124% +$316K ﹤0.01% 3219
2022
Q3 		$305K Buy
13,600
+12,300
+946% +$355K ﹤0.01% 3365
2022
Q2 		$32K Sell
1,300
-32,900
-96% -$908K ﹤0.01% 4442
2022
Q1 		$1.33M Buy
34,200
+32,600
+2,038% +$1.26M ﹤0.01% 1985
2021
Q4 		$94K Buy
+1,600
New +$90.7K ﹤0.01% 4411

Other funds holding FATE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Walleye Trading's FATE Position: Q1 2023 in Review

Walleye Trading sold out of Fate Therapeutics (FATE) in Q1 2023, closing a stake of 11,735 shares — an estimated $118K sold.

Walleye Trading first reported a position in FATE in Q2 2015 and held it in 7 quarters. The position peaked at $249K in Q4 2020. 181 funds tracked by Wall St. Rank hold FATE as of Q1 2023.

  • Walleye Trading reported no remaining Fate Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Walleye Trading sold 11,735 Fate Therapeutics shares in Q1 2023, an estimated $118K.
  • Walleye Trading first reported a position in Fate Therapeutics in Q2 2015 and held it in 7 quarters.
  • Walleye Trading's Fate Therapeutics position peaked at $249K in Q4 2020.
  • 181 funds tracked by Wall St. Rank held Fate Therapeutics as of Q1 2023.

Based on Walleye Trading's 13F filing for Q1 2023, filed 15 May 2023.